Translate to...

Trial finds drug safe and effective in treating hepatitis C during pregnancy

Critics of the new recommendation to screen all pregnant women for hepatitis C—a lifelong infection that attacks the liver—argue that it's wasteful to test for a disease among a population that can't be treated, but results of a small phase I clinical trial at Magee-Womens Research Institute (MWRI) suggest otherwise: pregnancy could be an excellent time to diagnose and cure hepatitis C infection.